Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
COVID-19, Canada and Pfizer
Fall 2024 COVID-19 guide: The status of COVID in Canada, available vaccines — and strains expected to dominate winter
Currently, the KP.3 and KP.3.1.1 FLiRT variants, derivatives of KP.1 and KP.2, are the most prevalent in Canada and the United States. As of Sept. 24, 72.1 per cent of COVID cases in Canada were from the KP.3.1.1 subvariant.
Pfizer/BioNTech Covid-19 Vaccine Adapted for KP.2 Strain Gets Canada Approval
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More.
Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK
The UK has become the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine, paving the way for mass vaccination. Britain's medicines regulator, the MHRA, says the jab, which offers up to 95% protection against Covid-19 illness,
Health Canada approves Pfizer-BioNTech's updated COVID-19 vaccine
BioNTech's updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.
Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal. Pfizer and its German partner BioNTech sued Moderna in London in September 2022,
Pfizer's updated COVID-19 vaccine approved, Health Canada says
Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada said on Tuesday.
Health Canada approves Pfizer's updated COVID-19 vaccine, manufacturer says
Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.
fingerlakes1
4h
Judge tosses family’s lawsuit over son’s vaccine-related death
A federal judge has dismissed a lawsuit by a New York family who claimed the Department of Defense misled Americans into ...
18h
Judge dismisses family lawsuit against Dept. of Defense after 24-year-old’s “vaccine-related” death
A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...
50m
NHS Covid booster jabs available within days to people born after specific year
The Covid booster jab autumn scheme is opening in just a few days with some Brits eligible and encouraged to get their ...
LAist
1d
A new round of free COVID tests is coming soon
At the end of September, each household will be able to order up to four rapid tests through COVIDtests.gov. The tests, which ...
2d
Updated Pfizer-BioNTech’s COVID-19 vaccine approved by Health Canada
Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...
Business Insider
7d
CHMP Recommends Marketing Authorization For Pfizer, BioNTech's Omicron KP.2-adapted COVID-19 Vaccine
(RTTNews) - Pfizer (PFE) and BioNTech SE (BNTX) announced that the CHMP of the European Medicines Agency has recommended marketing authorization for the companies' Omicron KP.2-adapted monovalent ...
50m
on MSN
NHS Covid booster jabs available within days to people born before specific year
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
STAT
1d
Pharmalittle: We’re reading about Pfizer pulling a sickle cell pill, Moderna getting scolded, and more
Pfizer
and its partner,
BioNTech
, sued Moderna in London in September 2022, seeking to revoke two patents held by Moderna ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback